Tobacco-Related Carcinoma Clinical Trial
Official title:
Informing Oral Nicotine Pouch Regulations to Promote Public Health
This clinical trial evaluates the characteristics of oral nicotine pouches (ONPs) to determine if they are a comparable substitute to cigarette or smokeless tobacco (ST) products. ONPs contain nicotine but no tobacco and are used primarily by adult tobacco uses in the United States (US). ONPs are recognized by the Food and Drug Administration as having lower risk than combustible cigarettes and are approved as a modified risk tobacco product. While ONPs have lower toxic risk than other tobacco products, acute and longer term harm related to their use has not been studied. Information gathered from this study may identify product characteristics of ONPs that improve successful switching from high-risk cigarettes or ST to lower risk ONPs.
PRIMARY OBJECTIVES: I. Assess the effects of nicotine concentration, form, and isomer on the satisfaction and appeal of ONPs relative to cigarettes and ST. II. Evaluate the effects of nicotine concentration, form, and isomer on switching from cigarettes or ST to ONPs. EXPLORATORY OBJECTIVE: I. Examine changes in oral microbiome-host interactions associated with degree of switching from cigarettes/ST to ONPs. OUTLINE: PHASE I: Participants are randomized to use one of the 4 study ONP products or their usual product brand of ST or cigarette in either the low or high nicotine concentration arm. ARM I: Participants insert low free-base nicotine (FBN) R/S ONP product over 30 minutes. Patients also undergo blood sample collection at 0, 5, 15, 30, 60, and 90 minutes. ARM II: Participants insert low FBN > 99% S ONP product over 30 minutes. Patients also undergo blood sample collection at 0, 5, 15, 30, 60, and 90 minutes. ARM III: Participants insert high R/S ONP product over 30 minutes. Patients also undergo blood sample collection at 0, 5, 15, 30, 60, and 90 minutes. ARM IV: Participants insert high FBN > 99% S ONP product over 30 minutes. Patients also undergo blood sample collection at 0, 5, 15, 30, 60, and 90 minutes. ARM V: Participants insert usual brand of ST over 30 minutes or smoke usual brand of cigarette over 5 minutes. Patients also undergo blood sample collection at 0, 5, 15, 30, 60, and 90 minutes. PHASE II: WASHOUT PERIOD: Participants use usual brand of ST or cigarettes for 1 week. CONTROL WEEK: Participants continue regular use of ST or cigarettes for 1 week and receive a text with a link to daily diary surveys to record tobacco use. PHASE II SWITCH: Participants are randomized to switch to 1 of 4 study ONP. ARM I: Participants insert low FBN R/S ONP for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection. ARM II: Participants insert to low FBN > 99% S ONP product for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection. ARM III: Participants insert to high R/S ONP product for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection. ARM IV: Participants insert high FBN > 99% S ONP product for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02964182 -
Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers
|
N/A | |
Completed |
NCT04267874 -
Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study
|
Early Phase 1 | |
Completed |
NCT04510077 -
SmartQuit Program for Smoking Cessation
|
N/A | |
Completed |
NCT03200236 -
The Lung Screening, Tobacco and Health Project
|
Phase 3 | |
Recruiting |
NCT06448351 -
Manipulating E-Cigarette Nicotine to Promote Public Health
|
N/A | |
Recruiting |
NCT05730439 -
Examining the Impact of Nicotine Pouches in Rural Ohio and Ohio Appalachia
|
Early Phase 1 | |
Recruiting |
NCT04949464 -
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
|
N/A | |
Not yet recruiting |
NCT06249984 -
Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
|
N/A | |
Enrolling by invitation |
NCT04969978 -
Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation
|
N/A | |
Completed |
NCT05972941 -
Nicotine and Tobacco Message Framing Among LGBT Young Adults
|
N/A | |
Completed |
NCT05453773 -
Hookah Additive Research to Inform Product Standards
|
N/A | |
Withdrawn |
NCT05411107 -
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
|
Phase 2 | |
Completed |
NCT03268993 -
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
|
N/A | |
Recruiting |
NCT04340531 -
Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities
|
Phase 4 | |
Terminated |
NCT04297332 -
Episodic Future Thinking and Future Thinking Priming for Smoking Cessation
|
N/A | |
Completed |
NCT03402230 -
Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers
|
Early Phase 1 | |
Recruiting |
NCT05876091 -
Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography
|
N/A | |
Completed |
NCT03182959 -
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
|
Early Phase 1 | |
Completed |
NCT05393869 -
Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
|
N/A | |
Recruiting |
NCT05679349 -
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
|
N/A |